메뉴 건너뛰기




Volumn 6, Issue OCT, 2015, Pages

Alloreactive natural killer cells for the treatment of acute myeloid leukemia: From stem cell transplantation to adoptive immunotherapy

Author keywords

Acute myeloid leukemia; Alloreactivity; Immunotherapy; Natural killer cells; Stem cell transplantation

Indexed keywords

CD56 ANTIGEN; CD94 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 35; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D;

EID: 84946559575     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00479     Document Type: Short Survey
Times cited : (40)

References (27)
  • 1
    • 84875230309 scopus 로고    scopus 로고
    • Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
    • Stern M, Passweg JR, Meyer-Monard S, Esser R, Tonn T, Soerensen J, et al. Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers. Bone Marrow Transplant (2013) 48:433-8. doi: 10.1038/bmt.2012.162.
    • (2013) Bone Marrow Transplant , vol.48 , pp. 433-438
    • Stern, M.1    Passweg, J.R.2    Meyer-Monard, S.3    Esser, R.4    Tonn, T.5    Soerensen, J.6
  • 2
    • 53549114206 scopus 로고    scopus 로고
    • NK cells and cancer immunosurveillance
    • Waldhauer I, Steinle A. NK cells and cancer immunosurveillance. Oncogene (2008) 27:5932-43. doi:10.1038/onc.2008.267.
    • (2008) Oncogene , vol.27 , pp. 5932-5943
    • Waldhauer, I.1    Steinle, A.2
  • 3
    • 10644291011 scopus 로고    scopus 로고
    • The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor
    • Borrego F, Masilamani M, Kabat J, Sanni TB, Coligan JE. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor. Mol Immunol (2005) 42:485-8. doi:10.1016/j.molimm.2004.07.031.
    • (2005) Mol Immunol , vol.42 , pp. 485-488
    • Borrego, F.1    Masilamani, M.2    Kabat, J.3    Sanni, T.B.4    Coligan, J.E.5
  • 4
    • 84883244752 scopus 로고    scopus 로고
    • Natural killer cell biology: an update and future directions
    • Campbell KS, Hasegawa J. Natural killer cell biology: an update and future directions. J Allergy Clin Immunol (2013) 132:536-44. doi:10.1016/j.jaci.2013.07.006.
    • (2013) J Allergy Clin Immunol , vol.132 , pp. 536-544
    • Campbell, K.S.1    Hasegawa, J.2
  • 5
    • 80053208226 scopus 로고    scopus 로고
    • Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
    • Curti A, Ruggeri L, D'Addio A, Bontadini A, Dan E, Motta MR, et al. Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. Blood (2011) 118:3273-9. doi:10.1182/blood-2011-01-329508.
    • (2011) Blood , vol.118 , pp. 3273-3279
    • Curti, A.1    Ruggeri, L.2    D'Addio, A.3    Bontadini, A.4    Dan, E.5    Motta, M.R.6
  • 6
    • 42449123606 scopus 로고    scopus 로고
    • Natural killer cell-directed therapies: moving from unexpected results to successful strategies
    • Terme M, Ullrich E, Delahaye NF, Chaput N, Zitvogel L. Natural killer cell-directed therapies: moving from unexpected results to successful strategies. Nat Immunol (2008) 9:486-94. doi:10.1038/ni1580.
    • (2008) Nat Immunol , vol.9 , pp. 486-494
    • Terme, M.1    Ullrich, E.2    Delahaye, N.F.3    Chaput, N.4    Zitvogel, L.5
  • 7
    • 67650433317 scopus 로고    scopus 로고
    • Natural killer cell-based immunotherapy in cancer: current insights and future prospects
    • Sutlu T, Alici E. Natural killer cell-based immunotherapy in cancer: current insights and future prospects. J Intern Med (2009) 266:154-81. doi:10.1111/j.1365-2796.2009.02121.x.
    • (2009) J Intern Med , vol.266 , pp. 154-181
    • Sutlu, T.1    Alici, E.2
  • 8
    • 0033168770 scopus 로고    scopus 로고
    • Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation
    • Ruggeri L, Capanni M, Casucci M, Volpi I, Tosti A, Perruccio K, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood (1999) 94:333-9.
    • (1999) Blood , vol.94 , pp. 333-339
    • Ruggeri, L.1    Capanni, M.2    Casucci, M.3    Volpi, I.4    Tosti, A.5    Perruccio, K.6
  • 9
    • 0037086131 scopus 로고    scopus 로고
    • Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
    • Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science (2002) 295:2097-100. doi:10.1126/science.1068440.
    • (2002) Science , vol.295 , pp. 2097-2100
    • Ruggeri, L.1    Capanni, M.2    Urbani, E.3    Perruccio, K.4    Shlomchik, W.D.5    Tosti, A.6
  • 10
    • 34347396957 scopus 로고    scopus 로고
    • Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value
    • Ruggeri L, Mancusi A, Capanni M, Urbani E, Carotti A, Aloisi T, et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood (2007) 110:433-40. doi:10.1182/blood-2006-07-038687.
    • (2007) Blood , vol.110 , pp. 433-440
    • Ruggeri, L.1    Mancusi, A.2    Capanni, M.3    Urbani, E.4    Carotti, A.5    Aloisi, T.6
  • 11
    • 63849104548 scopus 로고    scopus 로고
    • Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
    • Pende D, Marcenaro S, Falco M, Martini S, Bernardo ME, Montagna D, et al. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood (2009) 113:3119-29. doi:10.1182/blood-2008-06-164103.
    • (2009) Blood , vol.113 , pp. 3119-3129
    • Pende, D.1    Marcenaro, S.2    Falco, M.3    Martini, S.4    Bernardo, M.E.5    Montagna, D.6
  • 12
    • 8844228916 scopus 로고    scopus 로고
    • Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation
    • Passweg JR, Tichelli A, Meyer-Monard S, Heim D, Stern M, Kühne T, et al. Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation. Leukemia (2004) 18:1835-8. doi:10.1038/sj.leu.2403524.
    • (2004) Leukemia , vol.18 , pp. 1835-1838
    • Passweg, J.R.1    Tichelli, A.2    Meyer-Monard, S.3    Heim, D.4    Stern, M.5    Kühne, T.6
  • 13
    • 10744230735 scopus 로고    scopus 로고
    • Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors
    • Giebel S, Locatelli F, Lamparelli T, Velardi A, Davies S, Frumento G, et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood (2003) 102:814-9. doi:10.1182/blood-2003-01-0091.
    • (2003) Blood , vol.102 , pp. 814-819
    • Giebel, S.1    Locatelli, F.2    Lamparelli, T.3    Velardi, A.4    Davies, S.5    Frumento, G.6
  • 14
    • 0037111776 scopus 로고    scopus 로고
    • Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor
    • Davies SM, Ruggieri L, DeFor T, Wagner JE, Weisdorf DJ, Miller JS, et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor. Blood (2002) 100:3825-7. doi:10.1182/blood-2002-04-1197.
    • (2002) Blood , vol.100 , pp. 3825-3827
    • Davies, S.M.1    Ruggieri, L.2    DeFor, T.3    Wagner, J.E.4    Weisdorf, D.J.5    Miller, J.S.6
  • 15
    • 1642377663 scopus 로고    scopus 로고
    • Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors
    • Bornhäuser M, Schwerdtfeger R, Martin H, Frank KH, Theuser C, Ehninger G. Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors. Blood (2004) 103:2860-1. doi:10.1182/blood-2003-11-3893.
    • (2004) Blood , vol.103 , pp. 2860-2861
    • Bornhäuser, M.1    Schwerdtfeger, R.2    Martin, H.3    Frank, K.H.4    Theuser, C.5    Ehninger, G.6
  • 16
    • 33746031836 scopus 로고    scopus 로고
    • KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy
    • Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, et al. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biol Blood Marrow Transplant (2006) 12:828-36. doi:10.1016/j.bbmt.2006.04.008.
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 828-836
    • Hsu, K.C.1    Gooley, T.2    Malkki, M.3    Pinto-Agnello, C.4    Dupont, B.5    Bignon, J.D.6
  • 17
    • 10644264504 scopus 로고    scopus 로고
    • KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation
    • Malmberg KJ, Schaffer M, Ringdén O, Remberger M, Ljunggren HG. KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation. Mol Immunol (2005) 42:531-4. doi:10.1016/j.molimm.2004.07.037.
    • (2005) Mol Immunol , vol.42 , pp. 531-534
    • Malmberg, K.J.1    Schaffer, M.2    Ringdén, O.3    Remberger, M.4    Ljunggren, H.G.5
  • 18
    • 77957734984 scopus 로고    scopus 로고
    • Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
    • Cooley S, Weisdorf DJ, Guethlein LA, Klein JP, Wang T, Le CT, et al. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood (2010) 116:2411-9. doi:10.1182/blood-2010-05-283051.
    • (2010) Blood , vol.116 , pp. 2411-2419
    • Cooley, S.1    Weisdorf, D.J.2    Guethlein, L.A.3    Klein, J.P.4    Wang, T.5    Le, C.T.6
  • 19
    • 84929377752 scopus 로고    scopus 로고
    • Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality
    • Mancusi A, Ruggeri L, Urbani E, Pierini A, Massei MS, Carotti A, et al. Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality. Blood (2015) 125:3173-82. doi:10.1182/blood-2014-09-599993.
    • (2015) Blood , vol.125 , pp. 3173-3182
    • Mancusi, A.1    Ruggeri, L.2    Urbani, E.3    Pierini, A.4    Massei, M.S.5    Carotti, A.6
  • 20
    • 1542348559 scopus 로고    scopus 로고
    • Monitoring of a new approach of immunotherapy with allogeneic In-labelled NK cells in patients with renal cell carcinoma
    • Meller B, Frohn C, Brand JM, Lauer I, Schelper LF, von Hof K. Monitoring of a new approach of immunotherapy with allogeneic In-labelled NK cells in patients with renal cell carcinoma. Eur J Nucl Med Mol Imaging (2004) 31:403-7. doi:10.1007/s00259-003-1398-4.
    • (2004) Eur J Nucl Med Mol Imaging , vol.31 , pp. 403-407
    • Meller, B.1    Frohn, C.2    Brand, J.M.3    Lauer, I.4    Schelper, L.F.5    von Hof, K.6
  • 21
    • 20144388509 scopus 로고    scopus 로고
    • Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
    • Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood (2005) 105:3051-7. doi:10.1182/blood-2004-07-2974.
    • (2005) Blood , vol.105 , pp. 3051-3057
    • Miller, J.S.1    Soignier, Y.2    Panoskaltsis-Mortari, A.3    McNearney, S.A.4    Yun, G.H.5    Fautsch, S.K.6
  • 22
    • 77949898005 scopus 로고    scopus 로고
    • NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia
    • Rubnitz JE, Inaba H, Ribeiro RC, Pounds S, Rooney B, Bell T, et al. NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia. J Clin Oncol (2010) 28:955-9. doi:10.1200/JCO.2009.24.4590.
    • (2010) J Clin Oncol , vol.28 , pp. 955-959
    • Rubnitz, J.E.1    Inaba, H.2    Ribeiro, R.C.3    Pounds, S.4    Rooney, B.5    Bell, T.6
  • 23
    • 84902682889 scopus 로고    scopus 로고
    • Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein
    • Bachanova V, Cooley S, Defor TE, Verneris MR, Zhang B, McKenna DH, et al. Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein. Blood (2014) 123:3855-63. doi:10.1182/blood-2013-10-532531.
    • (2014) Blood , vol.123 , pp. 3855-3863
    • Bachanova, V.1    Cooley, S.2    Defor, T.E.3    Verneris, M.R.4    Zhang, B.5    McKenna, D.H.6
  • 25
    • 84872225254 scopus 로고    scopus 로고
    • Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors
    • Ni J, Miller M, Stojanovic A, Garbi N, Cerwenka A. Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J Exp Med (2012) 209:2351-65. doi:10.1084/jem.20120944.
    • (2012) J Exp Med , vol.209 , pp. 2351-2365
    • Ni, J.1    Miller, M.2    Stojanovic, A.3    Garbi, N.4    Cerwenka, A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.